Swiss pharma giant Roche is closing its only Irish manufacturing plant with the loss of 240 jobs. The closure of the company’s Clarecastle facility in(...)

Iseq heavyweight CRH had another good day. Photograph: Brenda Fitzsimons

European shares eased back yesterday, having already recouped nearly all their losses from a bruising 8 per cent drop earlier this week, with markets(...)

Roche shares fall as much as 4.1 per cent. Photograph: Reuters

Roche Holding AG, the world’s largest seller of cancer drugs, said the Swiss franc’s surge may strip 9 percentage points from growth in operating prof(...)

Dublin index heavyweight CRH added 1.17 per cent to close at €19.83

European markets rose as oil company gains helped to counterbalance a sharp fall in Swiss equities sparked by the country’s national bank decision to(...)

Aer Lingus ends day up at €2.14 on the back of about 730 trades. Photograph: Alan Betson

Mark Paul The Iseq in Dublin rose by 0.3 per cent as European stocks advanced for a fifth day, with banks contributing the most to the gains.Most US s(...)

Roche, the world’s largest maker of cancer drugs, will pay $74 a share for InterMune, an unprofitable biotechnology company that’s awaiting US approval of its biggest drug.Photograph: STEFFEN SCHMIDT/EPA

Roche Holding, the world’s largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to bu(...)

Tesco dropped 1 per cent to 300.6 pence. The company may report its worst UK sales in more than 10 years this week as discounters gain market share, Morgan Stanley predicted. Photograph; PA

European shares started the month positively yesterday, buoyed by upbeat economic data from China that helped to allay concerns about growth rates the(...)

Amgen employs about 250 people in Dublin in two sites in Dun Laoghaire andSantry.

US pharmaceutical group Amgen is to acquire Onyx Pharmaceuticals in a $10.4 billion (€7.8bn) deal that gives Amgen access to a rapidly expanding cance(...)

 AstraZeneca:  stock fell 0.2 per cent  in London yesterday  but has  gained 17 per cent this year. Photograph: Paul Thomas/Bloomberg

AstraZeneca chief financial officer Simon Lowth will leave the UK’s second-biggest drugmaker at the end of October to join natural-gas producer BG Gro(...)

A man with cancer rests on a bench on the pavement outside the Tata Memorial Hospital in Mumbai. Today’s landmark judgment has the potential to change the direction of India's pharmaceutical business. Photograph: Danish Siddiqui/Reuters

India's top court has dismissed Swiss company Novartis's attempt to win patent protection for its newly-updated cancer drug Glivec. The (...)